|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61K 47/14 | (2013.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 9/0095 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 9/10 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 2958550 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14710642.1 |
| Date of filing the European patent application | 2014-02-21 | |
| (97) | Date of publication of the European application | 2015-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/059161 |
| Date | 2014-02-21 |
| (87) | Number | WO 2014/128661 |
| Date | 2014-08-28 |
| (30) | Number | Date | Country code |
| 201361768803 P | 2013-02-25 | US |
| (72) |
DECAUDIN, Céline , CH
ROGUE, Vincent , CH
|
| (73) |
Sun Pharmaceutical Industries Limited ,
SPARC, TANDALJA, Vadodara, Gujarat-390012,
IN
|
| (54) | ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG |
| ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG |